Dyspnoea with progressive "idiopathic" pulmonary fibrosis

被引:1
|
作者
Puri, Chahat [1 ]
Harish, Vignesh [1 ]
Rhee, Kyunghoon [1 ]
Slack, Donald F. [2 ]
机构
[1] Greater Baltimore Med Ctr, Dept Internal Med, 6701 N Charles St, Towson, MD 21204 USA
[2] Greater Baltimore Med Ctr, Dept Pulm Med & Crit Care, Towson, MD USA
来源
RESPIROLOGY CASE REPORTS | 2021年 / 9卷 / 07期
关键词
Familial pulmonary fibrosis; interstitial lung disease; short telomeres;
D O I
10.1002/rcr2.800
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Telomeres are repetitive nucleotide sequences that prevent chromosomal shortening in cell replication. Short telomeres have been implicated in the pathogenesis of interstitial lung disease. Patients with short telomere related pulmonary fibrosis can have computed tomography (CT) findings inconsistent with pro-typical usual interstitial pneumonia/idiopathic pulmonary fibrosis (UIP/IPF) pattern. They can have rapid progression and overall worse prognosis. Antifibrotic drugs, like pirfenidone, can be used to slow the progression of disease, but there is conflicting data in patients with Telomerase reverse transcriptase/Telomerase RNA component (TERT/TERC) mutations, hence genetic testing plays an important role in determining the therapeutic options. These patients should be referred for lung transplantation early. We present a case of rapidly progressive pulmonary fibrosis associated with short telomere.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis
    Nishiyama, O.
    Taniguchi, H.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 476 - 477
  • [2] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [3] IDIOPATHIC PROGRESSIVE PULMONARY FIBROSIS
    DAVIES, D
    CROWTHER, JS
    MACFARLANE, A
    [J]. THORAX, 1975, 30 (03) : 316 - 325
  • [4] Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Liu, Gabrielle Y.
    Budinger, G. R. Scott
    Dematte, Jane E.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [5] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    [J]. RESPIROLOGY, 2023, 28 : 202 - 202
  • [6] A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
    Nishiyama, O.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kato, K.
    Kataoka, K.
    Ogawa, T.
    Watanabe, F.
    Arizono, S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (05) : 1067 - 1072
  • [7] THE IMPACT OF COUGH AND DYSPNOEA ON ANXIETY AND DEPRESSION IN IDIOPATHIC PULMONARY FIBROSIS
    Islam, R.
    Wu, Z.
    Smith, D. J. F.
    Maher, T. M.
    Smith, J. A.
    Molyneaux, P. L.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A245 - A246
  • [8] Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
    Scholand, Mary Beth
    Wells, Athol U.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (10) : 1296 - 1296
  • [9] Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis
    Behr, Juergen
    Bonella, Francesco
    Frye, Bjoern C.
    Guenther, Andreas
    Hagmeyer, Lars
    Henes, Joerg
    Klemm, Philipp
    Koschel, Dirk
    Kreuter, Michael
    Leuschner, Gabriela
    Nowak, Dennis
    Prasse, Antje
    Quadder, Bernd
    Sitter, Helmut
    Costabel, Ulrich
    [J]. PNEUMOLOGIE, 2023, 77 (02): : 94 - 119
  • [10] Developmental Reprogramming In Progressive Idiopathic Pulmonary Fibrosis
    Chanda, D.
    Kurundkar, A.
    Rangarajan, S.
    Locy, M. L.
    Bernard, K.
    Sharma, N. S.
    Logsdon, N. J.
    Liu, H.
    Crossman, D. K.
    Horowitz, J. C.
    Thannickal, V. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193